Observational Investigation of Thrombolysis With the Tissue-Type Plasminogen Activator Monteplase for Acute Pulmonary Embolism in Japan

Circulation Journal

Volumn 76, Issue 10, 2012, Pages 2471-2480

  Niwa, Akihiro ^a   Nakamura, Mashio ^b   Harada, Natsumi ^c   Musha, Takashi ^c  

^a Hiratsuka Kyosai Hospital   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c EISAI CO LTD   (Japan)

Author keywords

Acute pulmonary embolism; Thrombolysis; Tissue type plasminogen activator

Indexed keywords

MONTEPLASE;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN INFARCTION; CARDIOPULMONARY ARREST; CEREBELLUM HEMORRHAGE; CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FEMALE; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMIC STRESS; HUMAN; LUNG CIRCULATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PROGNOSIS; SHOCK; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; DISEASE-FREE SURVIVAL; FEMALE; HEMODYNAMICS; HUMANS; INTRACRANIAL HEMORRHAGES; JAPAN; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATORS; PULMONARY CIRCULATION; PULMONARY EMBOLISM; SURVIVAL RATE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84867877045     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0091     Document Type: Article

References (22)

1. Goldhaber SZ. Advanced treatment strategies for acute pulmonary embolism, including thrombolysis and embolectomy. J Thromb Haemost 2009; 7(Suppl 1): 322-327.
2. JCS Joint Working Group. Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009): Digest version. Circ J 2011; 75: 1258-1281.
3. Guideline committee of Japan Radiological Society and Japanese Collage of Radiology (editor). Guidelines for diagnostic imaging of venous thromboembolism 2007. http://www.jcr.or.jp/guideline/2007/pdf/2010_tuika.pdf (accessed May 7, 2012).
4. Sugimoto T, Shirato K, Kuriyama T, Kanazawa M, Motomiya T, Nakano T, et al. Clinical usefulness of a modified t-PA, E6010 for acute pulmonary embolism. Jpn Pharmacol Ther 2005; 33: 653-683.
5. Jerjes-Sanchez C, Ramírez-Rivera A, de Lourdes García M, Arriaga-Nava R, Valencia S, Rosado-Buzzo A, et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial. J Thromb Thrombolysis 1995; 2: 227-229.
6. Nakamura M, Fujioka H, Yamada N, Sakuma M, Okada O, Nakanishi N, et al. Clinical characteristics of acute pulmonary thromboembolism in Japan: Results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research. Clin Cardiol 2001; 24: 132-138.
7. Sakuma M, Nakamura M, Nakanishi N, Miyahara Y, Tanabe N, Yamada N, et al. Inferior vena cava filter is a new additional therapeutic option to reduce mortality from acute pulmonary embolism. Circ J 2004; 68: 816-821.
8. Tokyo CCU Network Scientific Committee. Latest management and outcomes of major pulmonary embolism in the cardiovascular disease early transport system: Tokyo CCU Network. Circ J 2010; 74: 289-293.
9. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W; Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347: 1143-1150.
10. Kucher N, Rossi E, Rosa MD, Goldhaber SZ. Massive pulmonary embolism. Circulation 2006; 113: 577-582.
11. Ohnishi A, Takazawa K, Fujita M, Shimomura M, Ishii M, Sanma H, et al. Phase study of the modified tissue plasminogen activator E6010. Rinsho Yakuri 1994; 25: 551.
12. Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galiè N, Pruszczyk P, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29: 2276-2315.
13. Tardy B, Venet C, Zeni F, Coudrot M, Guyomarc'h S, Mismetti P. Short term effect of recombinant tissue plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: Results of a meta-analysis involving 464 patients. Thromb Res 2009; 124: 672-677.
14. Nakamura M, Nakanishi N, Yamada N, Sakuma M, Miyahara Y, Okada O, et al. Effectiveness and safety of the thrombolytic therapy for acute pulmonary thromboembolism: Results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research. Int J Cardiol 2005; 99: 83-89.
15. Meyer G, Gisselbrecht M, Diehl JL, Journois D, Sors H. Incidence and predictors of major hemorrhagic complications from thrombolytic therapy in patients with massive pulmonary embolism. Am J Med 1998; 105: 472-477.
16. Janata K, Holzer M, Kürkciyan I, Losert H, Riedmüller E, Pikula B, et al. Major bleeding complications in cardiopulmonary resuscitation: The place of thrombolytic therapy in cardiac arrest due to massive pulmonary embolism. Resuscitation 2003; 57: 49-55.
17. Fiumara K, Kucher N, Fanikos J, Goldhaber SZ. Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism. Am J Cardiol 2006; 97: 127-129.
18. Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: A meta-analysis of the randomized controlled trials. Circulation 2004; 110: 744-749.
19. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-1389.
20. Kanter DS, Mikkola KM, Patel SR, Parker JA, Goldhaber SZ. Thrombolytic therapy for pulmonary embolism: Frequency of intracranial hemorrhage and associated risk factors. Chest 1997; 111: 1241-1245.
21. Hamel E, Pacouret G, Vincentelli D, Forissier JF, Peycher P, Pottier JM, et al. Thrombolysis on heparin therapy in massive pulmonary embolism with right ventricular dilation: Results from a 128-patients monocenter registry. Chest 2001; 120: 120-125.
22. Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser K, Rauber K, et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: Results of a multicenter registry. Circulation 1997; 96: 882-888.